Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
Become a Member | Sign in
Home>News>This Article

UT Southwestern Chair of Molecular Biology Wins 2012 Beering Award

Published: Tuesday, April 03, 2012
Last Updated: Tuesday, April 03, 2012
Bookmark and Share
Dr. Eric N. Olson wins Beering Award for outstanding advancements in biomedical or clinical science.

Dr. Eric N. Olson, chairman of molecular biology at UT Southwestern Medical Center, is the winner of the 2012 Steven C. Beering Award for outstanding advancements in biomedical or clinical science.

Dr. Olson is known for his work at the interface of developmental biology and medicine that identified major genetic pathways controlling the formation of the heart and other muscles. Several drugs based on his research are currently under study.

The award is given annually by the Indiana University School of Medicine.

At UT Southwestern, Dr. Olson directs the Nancy B. and Jake L. Hamon Center for Basic Research in Cancer and the Nearburg Family Center for Basic and Clinical Research in Pediatric Oncology.

A member of the National Academy of Sciences and the Institute of Medicine, Dr. Olson will present a lecture to medical students, graduate students, postdoctoral researchers and medical residents on the Indianapolis campus Oct. 16, followed by the Beering Award lecture on Oct. 17. The award includes a medal and a $25,000 prize.

Several Beering awardees have gone on to win the Nobel Prize. 1990 Beering winner Dr. Alfred G. Gilman, UT Southwestern professor emeritus of pharmacology and chief scientific officer for the Cancer Prevention and Research Institute of Texas, was awarded a Nobel in 1994.

The Passano Foundation recently named Dr. Olson the winner of the 2012 Passano Award, a $50,000 prize created in 1943 to honor U.S.-based research that leads to real-world applications.

Dr. Olson will accept that prize April 30 in Baltimore. Twenty-three Passano Award recipients have gone on to win the Nobel Prize including Dr. Gilman, Dr. Joseph L. Goldstein, chairman of molecular genetics; and his 1985 co-winner Dr. Michael S. Brown, director of the Erik Jonsson Center for Research in Molecular Genetics and Human Disease.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,600+ scientific posters on ePosters
  • More than 3,800+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Rapid Bone Loss Possible Side Effect of Anti-Obesity Drug
Research from UT Southwestern Medical Center has raised concern about the safe use of fibroblast growth factor 21.
Tuesday, February 07, 2012
Circuit Regulating Anti-Diabetic Actions of Serotonin Uncovered By UT Southwestern Researchers
A brain chemical known to help regulate emotion, mood and sleep – might also have anti-diabetic properties, findings suggest.
Friday, November 12, 2010
Brain Chemical Boosts Body Heat and Aids in Calorie Burn, Suggests Recent UT Southwestern Research
Newly found enzyme in the brain might control the increased generation of body heat that helps burn off excess calories after eating high-fat meals.
Thursday, July 08, 2010
Experimental Drug Shows Promise Against Brain, Prostate Cancers, UT Southwestern Researchers Find
Study shows that drug attacked not only the bulk of the tumor cells but also the rare cancer stem cells responsible for cancer’s growth.
Wednesday, January 06, 2010
Anemia Drug Not Helpful for Kidney Disease Patients, UT Southwestern Researcher Reports
Study concluds that the anemia drug darbepoetin alfa works no better than a placebo in several applications previously thought to be promising.
Thursday, December 24, 2009
Tiny Molecule Slows Progression of Lou Gehrig’s Disease in Mice, UT Southwestern Researchers Find
A molecule produced naturally by muscles in response to nerve damage can reduce symptoms and prolong life in ALS mouse model.
Tuesday, December 15, 2009
UT Southwestern Researchers Use Drug-Radiation Combo to Eradicate Lung Cancer
Researchers have eliminated non-small cell lung cancer in mice by using an investigative drug called BEZ235 in combination with low-dose radiation.
Friday, November 06, 2009
UT Southwestern Researchers Examine Mechanisms that Help Cancer Cells Proliferate
A process that limits the number of times a cell divides works much differently than had been thought, say researchers.
Thursday, September 03, 2009
Higher Drug Doses Needed to Defeat Tuberculosis, UT Southwestern Researchers Report
The typical dose of a medication considered pivotal in treating tuberculosis effectively is much too low to account for modern-day physiques, researchers say.
Monday, August 03, 2009
UT Southwestern Earns Grant from American Heart Association for Cardiac Myogenesis Research Center
The $2 million grant will help to study the development and mechanisms of generating new cardiac muscle cells.
Thursday, July 23, 2009
UT Southwestern Research Reveals How Cells Tell Time
In a new study researchers have found a mold that uses FRQ protein to mark time by a sequence of changes in the protein’s chemical structure.
Wednesday, June 10, 2009
UT Southwestern Researchers Probe Kidney Damage, Protection in Lupus
Researchers also found that a certain set of genes appears to protect the kidneys from a different sort of immune attack.
Monday, April 27, 2009
UT Southwestern Researchers Find Marker for Severity in Adult Brain Cancer
Researchers have identified a new biological indicator that may help identify which brain-cancer patients have the most aggressive forms of the disease.
Thursday, April 16, 2009
UT Southwestern Researchers Disrupt Biochemical System Involved in Cancer, Degenerative Disease
Researchers identify two new chemical compounds that can be used to study and manipulate a cellular pathway involved in cancer and degenerative diseases.
Monday, February 02, 2009
Natural Brain Substance Blocks Weight Gain in Mice, UT Southwestern Researchers Discover
The chemical, orexin, works by increasing the body’s sensitivity to the weight-loss hormone, the researchers report.
Thursday, January 29, 2009
Scientific News
Atriva Therapeutics GmbH Develops Innovative Flu Drug
Highly effective against seasonal and pandemic influenza.
Study Removes Cancer Doubt for Multiple Sclerosis Drug
Researchers from Queen Mary University of London are calling on the medical community to reconsider developing a known drug to treat people with relapsing Multiple sclerosis after new evidence shows it does not increase the risk of cancer as previously thought.
New Hope for Personalized Treatment of Eczema
Pharmaceutical researchers at Oregon State University have developed a new approach to treat eczema and other inflammatory skin disorders that would use individual tests and advanced science to create personalized treatments based on each person's lipid deficiencies.
Inroads Against Leukaemia
Potential for halting disease in molecule isolated from sea sponges.
Researchers Disguise Drugs As Platelets to Target Cancer
Researchers have for the first time developed a technique that coats anticancer drugs in membranes made from a patient’s own platelets.
HIV Patients Should Be Included in Early Clinical Trials of Anti-TB Drugs
Tuberculosis is the number one cause of death in HIV-infected patients in Africa and a leading cause of death in this population worldwide.
Combination Drug Therapy Shrinks Pancreatic Tumors In Mice
Two drugs that affect the structure and function of DNA have been found to block the growth of pancreatic tumor cells in mice, researchers hope the drugs can soon be tested in humans with the disease.
Seeking A Better Way To Design Drugs
NIH funds research at Worcester Polytechnic Institute to advance a new chemical process for more effective drug development and manufacturing.
Old Drug Performs New Tricks
Cambridge-led research reveals the powers of a "wonder drug" that has lain under the noses of doctors for 50 years.
Diabetes Drugs May Actually Release Sugar Into the Blood
A family of drugs used to treat Type 2 diabetes could promote the release of sugars into the blood - something the drugs are supposed to prevent, Cambridge scientists have claimed.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos